| Literature DB >> 33368180 |
Edvard Johansson1, Roope A Kallionpää2, Petri Böckerman3,4,5, Juha Peltonen2, Sirkku Peltonen6,7,8,9.
Abstract
Rare heritable syndromes may affect educational attainment. Here, we study education in neurofibromatosis 1 (NF1) that is associated with multifaceted medical, social and cognitive consequences. Educational attainment in the Finnish population-based cohort of 1408 individuals with verified NF1 was compared with matched controls using Cox proportional hazards model with delayed entry and competing risk for death. Moreover, models accounting for the effects of cancer at age 15-30 years, parental NF1 and developmental disorders were constructed. Overall, the attainment of secondary education was reduced in individuals with NF1 compared to controls (hazard ratio 0.83, 95%CI 0.74-0.92). History of cancer and developmental disorders were major predictors of lack of secondary education. Individuals with NF1 obtained vocational secondary education more often than general upper secondary education. Consequently, NF1 decreased the attainment of Bachelor's and Master's degrees by 46%-49% and 64%-74%, respectively. Surprisingly, the non-NF1 siblings of individuals with NF1 also had lower educational attainment than controls, irrespective of parental NF1. In conclusion, NF1 is associated with reduced educational attainment and tendency for affected individuals to obtain vocational instead of academic education. Individuals living with NF1, especially those with cancer, developmental disorders or familial NF1, need effective student counseling and learning assistance.Entities:
Keywords: educational attainment; multiorgan syndrome; neurofibromatosis 1; rare disease; school performance
Mesh:
Year: 2021 PMID: 33368180 PMCID: PMC8247857 DOI: 10.1111/cge.13907
Source DB: PubMed Journal: Clin Genet ISSN: 0009-9163 Impact factor: 4.438
Characteristics of the cohorts
| Individuals with NF1 | Control persons | Siblings without NF1 | |
|---|---|---|---|
| N | 1408 | 14 012 | 2042 |
| Sex | |||
|
| 677 (48.1) | 6758 (48.2) | 1059 (51.9) |
|
| 731 (51.9) | 7254 (51.8) | 983 (48.1) |
| Year of birth, mean (SD) | 1974 (22.4) | 1974 (22.4) | 1976 (19.1) |
| Start of follow‐up (cohort entry) | |||
|
| 23.6 (20.7) | 23.6 (20.7) | 22.0 (17.1) |
|
| 1991 (6.1) | 1991 (6.1) | 1991 (6.7) |
| End of follow‐up | |||
|
| 39.7 (20.7) | 41.3 (21.4) | 38.9 (18.7) |
|
| 2014 (5.7) | 2015 (3.3) | 2015 (3.2) |
| Follow‐up time, mean (SD) | 23.0 (7.4) | 24.6 (6.5) | 24.5 (7.1) |
| Deaths during the follow‐up | |||
|
| 276 (19.6) | 1071 (7.6) | 108 (5.3) |
|
| 54.3 (21.6) | 66.9 (17.4) | 51.5 (14.3) |
| Persons with history of cancer | |||
|
| 65 (4.6) | 55 (0.4) | 7 (0.4) |
| History of ICD‐10 diagnosis F70–F98, n (%) | 230 (44.6) | 525 (10.2) | 99 (14.8) |
|
| 30 (5.8) | 25 (0.5) | 12 (1.8) |
|
| 224 (43.4) | 521 (10.2) | 92 (13.7) |
| Parental NF1, n (%) | 579 (41.1) | ‐ | 511 (25.0) |
| Area of residence | |||
|
| 1218 (86.5) | 11 924 (85.1) | 1667 (81.7) |
|
| 190 (13.5) | 2088 (14.9) | 373 (18.3) |
| Highest level of education obtained by the end of follow‐up | |||
|
| 565 (40.1) | 4719 (33.7) | 674 (33.0) |
|
| 83 (5.9) | 1681 (12.0) | 217 (10.6) |
|
| 572 (40.6) | 3810 (27.2) | 644 (31.6) |
|
| 150 (10.7) | 2562 (18.3) | 361 (17.7) |
|
| 38 (2.7) | 1240 (8.8) | 144 (7.1) |
Abbreviations: ICD‐10, international classification of diseases, 10th revision; ISCED, international standard classification of education; NF1, neurofibromatosis type 1; SD, standard deviation.
Information available for 1893 siblings without NF1.
Among persons born in 1987 or later: 516 individuals with NF1, 5124 control persons and 671 siblings without NF1.
The effect of neurofibromatosis type 1 (NF1) on graduation from secondary education
| All secondary education | General upper secondary education | Vocational education | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Model 1 all persons | Model 2 all persons | Model 3 persons born 1987 or later | Model 1 all persons | Model 2 all persons | Model 3 persons born 1987 or later | Model 1 all persons | Model 2 all persons | Model 3 persons born 1987 or later | |
| Individuals with NF1 vs. control persons | |||||||||
| NF1 |
|
|
|
|
|
|
|
|
|
| Female | 1.12 [1.04,1.21] | 1.13 [1.04,1.22] | 1.10 [1.02,1.18] | 1.55 [1.35,1.77] | 1.55 [1.35,1.78] | 1.54 [1.36,1.76] | 0.63 [0.55,0.71] | 0.63 [0.55,0.71] | 0.69 [0.61,0.79] |
| Cancer at age 15–30 years | – | 0.59 [0.44,0.80] | 0.96 [0.65,1.42] | – | 0.70 [0.44,1.10] | 0.78 [0.41,1.50] | – | 0.60 [0.41,0.89] | 0.76 [0.42, 1.35] |
| Parental NF1 | – | 0.83 [0.67,1.02] | 0.89 [0.72,1.11] | – | 0.62 [0.42,0.92] | 0.83 [0.50,1.40] | – | 1.08 [0.85,1.38] | 1.05 [0.79,1.38] |
| Urban area of residence | – | 0.98 [0.92,1.04] | 0.97 [0.90,1.05] | – | 1.10 [0.98,1.24] | 1.07 [0.93,1.24] | – | 0.61[0.55,0.68] | 0.68 [0.60,0.78] |
| Diagnosis F70–F98 | – | – | 0.60 [0.53,0.67] | – | – | 0.45 [0.35,0.57] | – | – | 1.08 [0.94,1.25] |
| n, observations (n, NF1) | 31 229 (2947) | 31 229 (2947) | 13 448 (1296) | 56 177 (6420) | 56 177 (6420) | 18 763 (1977) | 64 283 (4213) | 64 283 (4213) | 19 981 (1565) |
| n, subjects (n, NF1) | 6954 (620) | 6954 (620) | 3788 (337) | 6968 (623) | 6968 (623) | 3788 (377) | 6954 (620) | 6954 (620) | 3788 (337) |
| n, events (n, NF1) | 5581 (464) | 5581 (464) | 2767 (226) | 3054 (129) | 3054 (129) | 1449 (61) | 2573 (337) | 2573 (337) | 1332 (165) |
| n, competing (n, NF1) | 43 (20) | 43 (20) | <17 (<10) | 70 (39) | 70 (39) | <18 (<10) | 60 (26) | 60 (26) | <17 (<10) |
| Individuals with NF1 vs. siblings without NF1 | |||||||||
| NF1 |
|
|
|
|
|
|
|
|
|
| Female | 1.19 [1.06,1.35] | 1.21 [1.07,1.37] | 1.03 [0.90,1.19] | 2.03 [1.64,2.53] | 2.05 [1.64,2.58] | 1.63 [1.21,2.20] | 0.66[0.56,0.79] | 0.68[0.57,0.81] | 0.71 [0.58,0.88] |
| Cancer at age 15–30 years | – | 0.52 [0.34,0.81] | 0.82 [0.46,1.45] | – | 0.83 [0.44,1.55] | 1.85 [0.83,4.15] | – | 0.47[0.28,0.79] | 0.43 [0.20,0.95] |
| Parental NF1 | – | 0.93 [0.80,1.09] | 0.95 [0.81,1.12] | – | 0.76 [0.57,1.02] | 0.64 [0.44,0.92] | – | 1.18[0.97,1.45] | 1.26 [1.01,1.56] |
| Urban area of residence | – | 0.87 [0.76,1.00] | 0.87 [0.75,1.00] | – | 1.27 [0.93,1.74] | 1.62 [1.05,2.46] | – | 0.57[0.47,0.69] | 0.55 [0.44,0.67] |
| Diagnosis F70–F98 | – | – | 0.63 [0.52, 0.74] | – | – | 0.34 [0.21,0.55] | – | – | 1.07 [0.85,1.34] |
| n, observations (n, NF1) | 7370 (2947) | 7201 (2947) | 2971 (1296) | 14 847 (6420) | 14 545 (6420) | 4478 (1977) | 12 362 (4213) | 11 978 (4213) | 3986 (1565) |
| n, subjects (n, NF1) | 1530 (620) | 1495 (620) | 787 (337) | 1535 (623) | 1500 (623) | 787 (337) | 1530 (620) | 1495 (620) | 787 (337) |
| n, events (n, NF1) | 1191 (464) | 1160 (464) | 549 (226) | 483 (129) | 464 (129) | 214 (61) | 720 (337) | 707 (337) | 336 (165) |
| n, competing (n, NF1) | 28 (20) | 28 (20) | 6 (5) | 50 (39) | 50 (39) | 8 (7) | 36 (26) | 31 (26) | 6 (5) |
In accordance with the privacy regulations of Statistics Finland, the exact number is not shown where n < 5, or case numbers <5 can be inferred from the data shown in this and other tables.
Note: The results (hazard ratios and 95% confidence intervals) are shown for models adjusted for sex only (model 1) and models adjusted for additional factors (model 2: Adjusted for sex, cancer diagnosis at 15–30 years of age, parental NF1 and area of residence; model 3: Adjusted also for diagnoses F70–F98). In the analyses, event was defined as achieving the educational level of interest, and death was considered as a competing risk. End of follow‐up due to other reasons led to censoring.
Sex‐stratified analysis of the effect of neurofibromatosis type 1 (NF1) on graduation from secondary education
| All secondary education | General upper secondary education | Vocational education | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Model 1 all persons | Model 2 all persons | Model 3 persons born 1987 or later | Model 1 all persons | Model 2 all persons | Model 3 persons born 1987 or later | Model 1 all persons | Model 2 all persons | Model 3 persons born 1987 or later | |
| Individuals with NF1 vs. control persons, WOMEN | |||||||||
| NF1 |
|
|
|
|
|
|
|
|
|
| Cancer at age 15–30 years | – | 0.60 [0.42,0.85] | 0.78 [0.46,1.32] | – | 0.59 [0.34,1.02] | 0.63 [0.29,1.39] | – | 0.70 [0.44,1.12] | 0.62 [0.26,1.46] |
| Parental NF1 | – | 0.91 [0.68,1.22] | 1.14 [0.84,1.56] | – | 0.51 [0.31,0.85] | 0.71 [0.38,1.35] | – | 1.65 [1.13,2.41] | 1.64 [1.02,2.63] |
| Urban area of residence | – | 0.99 [0.91,1.08] | 1.01 [0.91,1.12] | – | 0.95 [0.81,1.11] | 0.90 [0.75,1.07] | – | 0.72 [0.61,0.85] | 0.80 [0.65,1.00] |
| Diagnosis F70–F98 | – | – | 0.53 [0.43,0.66] | – | – | 0.32 [0.20,0.49] | – | – | 1.39 [1.08,1.78] |
| n, observations (n, NF1) | 14 461 (1394) | 14 461 (1394) | 5814 (575) | 25 051 (2945) | 25 051 (2945) | 7803 (838) | 33 731 (2251) | 33 731 (2251) | 9424 (748) |
| n, subjects (n, NF1) | 3322 (294) | 3322 (294) | 1705 (151) | 3336 (297) | 3336 (297) | 1705 (151) | 3322 (294) | 3322 (294) | 1705 (151) |
| n, events (n, NF1) | 2750 (226) | 2750 (226) | 1276 (102) | 1725 (85) | 1725 (85) | 775 (39) | 1054 (142) | 1054 (142) | 509 (63) |
| n, competing (n, NF1) | 12 (8) | 12 (8) | <5 (<5)a | 22 (16) | 22 (16) | <5 (<5) | 22 (11) | 22 (11) | <5 (<5) |
| Individuals with NF1 vs. control persons, MEN | |||||||||
| NF1 |
|
|
|
|
|
|
|
|
|
| Cancer at age 15–30 years | – | 0.64 [0.38,1.08] | 1.30 [0.78,2.15] | – | 0.96 [0.44,2.08] | 1.15 [0.40,3.32] | – | 0.55 [0.29,1.05] | 0.90 [0.40,2.05] |
| Parental NF1 | – | 0.76 [0.57,1.01] | 0.76 [0.56,1.02] | – | 0.85 [0.45,1.61] | 0.98 [0.42,2.31] | – | 0.81 [0.58,1.12] | 0.82 [0.57,1.17] |
| Urban area of residence | – | 0.97 [0.88,1.06] | 0.94 [0.85,1.05] | – | 1.33 [1.12,1.59] | 1.35 [1.08,1.70] | – | 0.55 [0.48,0.64] | 0.62 [0.53,0.73] |
| Diagnosis F70–F98 | – | – | 0.64 [0.56,0.72] | – | – | 0.57 [0.43,0.74] | – | – | 0.97 [0.82,1.16] |
| n, observations (n, NF1) | 16 768 (1553) | 16 768 (1553) | 7634 (721) | 31 126 (3475) | 31 126 (3475) | 10 960 (1139) | 30 552 (1962) | 30 552 (1962) | 10 557 (817) |
| n, subjects (n, NF1) | 3632 (326) | 3632 (326) | 2083 (186) | 3632 (326) | 3632 (326) | 2083 (186) | 3632 (326) | 3632 (326) | 2083 (186) |
| n, events (n, NF1) | 2831 (238) | 2831 (238) | 1491 (124) | 1329 (44) | 1329 (44) | 674 (22) | 1519 (195) | 1519 (195) | 823 (102) |
| n, competing (n, NF1) | 31 (12) | 31 (12) | 12 (<5) | 48 (23) | 48 (23) | 13 (<5) | 38 (15) | 38 (15) | 12 (<5) |
In accordance with the privacy regulations of Statistics Finland, the exact number is not shown where n < 5, or case numbers <5 can be inferred from the data shown in this and other tables.
Note: The results (hazard ratios and 95% confidence intervals) are shown for unadjusted models (model 1) and models adjusted for additional factors (model 2: Adjusted for cancer diagnosis at 15–30 years of age, parental NF1 and area of residence; model 3: Adjusted also for diagnoses F70–F98). In the analyses, event was defined as achieving the educational level of interest, and death was considered as a competing risk. End of follow‐up due to other reasons led to censoring.
Educational field of the highest degree obtained among individuals with neurofibromatosis type 1 (NF1), their siblings without NF1 and matched controls without NF1. The numbers are n (%)
| Individuals with NF1 | Control persons | Siblings without NF1 | ||||
|---|---|---|---|---|---|---|
| Secondary | At least bachelor | Secondary | At least bachelor | Secondary | At least bachelor | |
| Generic | 44 (6.6) | <5 (<2.8) | 1147 (20.5) | <5 (<0.1) | 140 (16.3) | <5 (<1.0) |
| Education | <5 (<0.8) | 7 (4.0) | 7 (0.1) | 270 (7.4) | <5 (<0.6) | 31 (6.1) |
| Arts and humanities | 30 (4.5) | 16 (9.0) | 168 (3.0) | 349 (9.6) | 34 (3.9) | 38 (7.5) |
| Social sciences, journalism and information | <5 (<0.8) | <5 (<2.8) | <5 (<0.1) | 193 (5.3) | <5 (<0.6) | 22 (4.4) |
| Business, administration and law | 64 (9.6) | 56 (31.6) | 540 (9.6) | 907 (24.9) | 73 (8.5) | 119 (23.6) |
| Natural sciences, mathematics and statistics | <5 (<0.8) | 8 (4.5) | 9 (0.2) | 136 (3.7) | <5 (<0.6) | 18 (3.6) |
| Information and communication technology | 24 (3.6) | 11 (6.2) | 100 (1.8) | 190 (5.2) | 12 (1.4) | 40 (7.9) |
| Engineering, manufacturing and construction | 187 (28.1) | 25 (14.1) | 1697 (30.3) | 646 (17.7) | 292 (33.9) | 100 (19.8) |
| Agriculture, forestry, fisheries and veterinary | 33 (5.0) | <5 (<2.8) | 257 (4.6) | 100 (2.7) | 49 (5.7) | 17 (3.4) |
| Health and welfare | 93 (14.0) | 37 (20.9) | 681 (12.2) | 666 (18.3) | 102 (11.8) | 96 (19.0) |
| Services | 191 (28.7) | 9 (5.1) | 997 (17.8) | 191 (5.2) | 158 (18.4) | 24 (4.8) |
| Unknown | <5 (<0.8) | <5 (<2.8) | <5 (<0.1) | <5 (<0.1) | <5 (<0.6) | <5 (<1.0) |
In accordance with the privacy regulations of Statistics Finland, the exact number is not shown where n < 5, or case numbers <5 can be inferred from the data shown in this and other tables.
The effect of neurofibromatosis type 1 (NF1) on graduation from higher education
| Bachelor's degree | Master's degree | |||||
|---|---|---|---|---|---|---|
| Model 1 all persons | Model 2 all persons | Model 3 persons born 1987 or later | Model 1 all persons | Model 2 all persons | Model 3 persons born 1987 or later | |
| Individuals with NF1 vs. control persons | ||||||
| NF1 |
|
|
|
|
|
|
| Female | 1.79 [1.59,2.01] | 1.78 [1.58,2.00] | 2.04 [1.57,2.63] | 1.56 [1.30,1.88] | 1.55 [1.29,1.86] | 1.66 [1.04,2.64] |
| Cancer at age 15–30 years | – | 1.01 [0.65,1.56] | 2.16 [1.11,4.21] | – | 1.02 [0.51,2.05] | 4.2 × 10−9 [2.2 × 10−9, 8.2 × 10−9] |
| Parental NF1 | – | 0.59 [0.37,0.95] | 0.49 [0.22,1.12] | – | 0.58 [0.22,1.53] | 1.64 [0.15,17.4] |
| Urban area of residence | – | 1.54 [1.29,1.83] | 1.85 [1.29,2.66] | – | 2.72 [2.01,3.67] | 3.48 [1.50,8.08] |
| Diagnosis F70–F98 | – | – | 0.11 [0.05,0.23] | – | – | 0.13 [0.035,0.50] |
| n, observations (n, NF1) | 77 147 (7058) | 77 147 (7058) | 24 290 (2197) | 84 771 (7577) | 84 771 (7577) | 25 173 (2245) |
| n, subjects (n, NF1) | 6968 (623) | 6968 (623) | 3788 (337) | 6968 (623) | 6968 (623) | 3788 (337) |
| n, events (n, NF1) | 1513 (77) | 1513 (77) | 462 (22) | 705 (18) | 705 (18) | 128 (<5) |
| n, competing (n, NF1) | 69 (38) | 69 (38) | 16 (7) | 85 (43) | 85 (43) | 16 (7) |
| Individuals with NF1 vs. siblings without NF1 | ||||||
| NF1 |
|
|
|
|
|
|
| Female | 2.10 [1.58, 2.56] | 1.97 [1.54,2.52] | 2.14 [1.34,3.40] | 1.83 [1.20,2.80] | 1.71 [1.09,2.70] | 3.58 [0.84, 15.3] |
| Cancer at age 15–30 years | – | 1.07 [0.56,2.07] | 3.77 [1.65,8.61] | – | 1.99 [0.64,6.16] | 0.7 × 10−6 [0.2 × 10−6, 0.3 × 10−5] |
| Parental NF1 | – | 0.73 [0.55,0.98] | 0.53 [0.31,0.98] | – | 0.50 [0.27,0.93] | 0.46 [0.12, 1.74] |
| Urban area of residence | – | 1.47 [1.01,2.15] | 2.29 [0.98,5.33] | – | 1.78 [0.84,3.77] | 1.9 × 106 [8.8 × 105, 4.2 × 106] |
| Diagnosis F70–F98 | – | – | 0.25 [0.11,0.55] | – | – | 0.42 [0.07,2.62] |
| n, observations (n, NF1) | 17 742 (7058) | 17 290 (7058) | 5318 (2197) | 19 295 (7577) | 18 793 (7577) | 5841 (2245) |
| n, subjects (n, NF1) | 1535 (623) | 1500 (623) | 787 (337) | 1535 (623) | 1500 (623) | 787 (337) |
| n, events (n, NF1) | 280 (77) | 272 (77) | 85 (22) | 92 (18) | 87 (18) | 9 (<5) |
| n, competing (n, NF1) | 53 (42) | 55 (42) | 8 (7) | 56 (43) | 53 (43) | 8 (7) |
In accordance with the privacy regulations of Statistics Finland, the exact number is not shown where n < 5, or case numbers <5 can be inferred from the data shown in this and other tables.
Note: The results (hazard ratios and 95% confidence intervals) are shown for models adjusted for sex only (model 1) and models adjusted for additional factors (model 2: Adjusted for sex, cancer diagnosis at 15–30 years of age, parental NF1 and area of residence; model 3: Adjusted also for diagnoses F70–F98). In the analyses, event was defined as achieving the educational level of interest, and death was considered as a competing risk. End of follow‐up due to other reasons led to censoring.